ConferenceSeries

International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

 
Yuming Xu

Yuming Xu

The First Affiliated Hospital of Zhengzhou University, China

Title: Spinocerebellar Ataxia type 3 responsive to nerve growth factor (Nobex)

Biography

Prof. Yuming Xu has completed his PhD at the age of 42 years from Huazhong University of Science and Technology. He is the director of Department of Neurology, director of the Department of Teaching and Research, the First Affiliated Hospital of Zhengzhou University. He has published more than 50 papers in SCI and/or SCIE journals and serving as an editorial board member of s series of repute journals like Life Science Journal, Chinese Medical Journal, Chinese Journal of Neurology, Chinese Journal of Stroke.

Abstract

Spinocerebellar ataxia type 3 (SCA3) is the most common type of SCA with few effective therapeutic measures. We report a case of a SCA3 patient responsive to nerve growth factor (NGF). A 46-year-old female patient genetically confirmed SCA3 and family history came to our clinic. On neurological examination, she had horizontal nystagmus, decreased muscle tone, increased tendon reflex, normal muscle power, and no pyramidal sign in the four limbs. The vibration sense was decreased in both feet, and dysdiadochokinesia was found in both hands. Electrophysiological tests revealed that the somatosensory evoked potential (SSEP) was unremakrable in the bilateral upper limbs but absent in bilateral lower limbs, the remainders of the tests were normal. After written informed consent was obtained, we solely administered NGF (Nobex) to this patient by intramuscular injection at a dose of 18 µg/d for 28 days consecutively. One of our movement disorder specialists performed Scale for the Assessment and Rating of Ataxia (SARA) and took the videos before and after therapy. Another movement disorder specialist independently blindly evaluated the above videos with SARA. The baseline average SARA score was 13 and decreased to 6 after 28 days of therapy. This patient was discharged home and followed-up for half a year. At 3 months and 6 months after therapy, the SARA score was 5 and 4 respectively. The follow-up SSEP performed at 6 months after therapy also showed improvement, and the latency phase of P40 was 40.50 ms in the left side and 37.83 ms in the right side.

Speaker Presentations

Speaker PDFs

Conference Series Destinations

Contact Us

Medical Conferences
Jessie Grace
jessie.grace@conferenceseries.com
1-702-508-5200 Ext:8031, 8041

Pharmaceutical Conferences
Badoni Victor
badoni.victor@conferenceseries.com
1-702-508-5200 Ext:8045, 8047

Immunology & Microbiology Conferences
Walker Smith
walker.smith@conferenceseries.com
1-702-508-5200 Ext:8031

Cancer Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Nursing and Healthcare Conferences
Jennifer Leny
jennifer.leny@conferenceseries.com
1-702-508-5200 Ext:8044

Diabetes Conferences
Stanley knight
stanley.knight@conferenceseries.com
1-702-508-5200 Ext:8040

Neuroscience Conferences
Sandeep Kumar
sandeep@conferenceseries.com
1-702-508-5200 Ext:8034

Dental Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Clinical and Biochemistry Conferences
Rohit Casper
rohit.casper@conferenceseries.com
1-702-508-5200 Ext:8033

Biotechnology Conferences
Ravi Vittal
ravi.vittal@conferenceseries.com
1-702-508-5200 Ext:8031, 8037

Material Science Conferences
Lucy Grey
lucygrey@conferenceseries.com
1-702-508-5200 Ext:8035

Genetics & Mol Biology Conferences
Stephen Bruce
stephen.bruce@conferenceseries.com
1-702-508-5200 Ext:8038

Engineering Conferences
Dolly A
dolly@conferenceseries.com
+1-702-508-5200 Ext:8051

Program Enquiries
Symposia/Workshops
Sponsorships
Media Partners | Advertising